Quanterix
Quanterix Plans to Wrap up Restructuring by End of Year; Q3 Revenues Grow 18 Percent
The company posted Q3 2023 revenues of $31.3 million, up from $26.6 million in Q3 2022 and beating the consensus Wall Street estimate of $27.6 million.
New Products Posted to GenomeWeb: OGT, IntelliSeq, Personalis, NeoGenomics, Quanterix, C2N, More
New products and services posted to GenomeWeb for the week of Oct. 23, 2023
GenomeWeb Top 40 Down 10 Percent in September, Outpacing Decline in Broader Market
In September, the Dow Jones Industrial Average was down 4 percent, the Nasdaq was down 6 percent, and the Nasdaq Biotech Index was down 4 percent.
People in the News at Scale Biosciences, Element Biosciences, Quanterix, More
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 21, 2023.
People in the News at Illumina, Karius, Ginkgo Bioworks, Quanterix
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 7, 2023.
Aug 8, 2023
Quanterix Q2 Revenues Rise 32 Percent
Mar 6, 2023
Quanterix Q4 Revenues Down 15 Percent
Aug 15, 2022
Canaccord Downgrades Quanterix From Buy to Hold
Aug 9, 2022
May 10, 2022
Quanterix Q1 Revenues up 9 Percent
Mar 1, 2022